tiprankstipranks
Wuxi Biologics (Cayman) Inc. (DE:1FW2)
FRANKFURT:1FW2
Germany Market
1FW2
Wuxi Biologics (Cayman)
RESEARCH TOOLSreports

Wuxi Biologics (Cayman) (1FW2) Stock Forecast & Price Target

4 Followers
See the Price Targets and Ratings of:

1FW2 Analyst Ratings

Strong Buy
12Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Wuxi
Biologics (Cayman)
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1FW2 Stock 12 Month Forecast

Average Price Target

€4.97
▲(29.11% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Wuxi Biologics (Cayman) in the last 3 months. The average price target is €4.97 with a high forecast of €5.98 and a low forecast of €4.06. The average price target represents a 29.11% change from the last price of €3.85.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"€1","6":"€6","2.25":"€2.25","3.5":"€3.5","4.75":"€4.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5.97608177,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€5.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.970837330833333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€4.97</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.057901,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€4.06</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.25,3.5,4.75,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,3.9212370592307693,4.0924741184615385,4.263711177692308,4.434948236923077,4.606185296153846,4.777422355384616,4.948659414615385,5.119896473846154,5.291133533076923,5.462370592307693,5.633607651538462,5.804844710769231,{"y":5.97608177,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,3.8439105639102564,3.937821127820513,4.031731691730769,4.125642255641026,4.219552819551282,4.313463383461539,4.407373947371795,4.5012845112820505,4.595195075192307,4.689105639102563,4.78301620301282,4.876926766923076,{"y":4.970837330833333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,3.7736846923076923,3.7973693846153846,3.821054076923077,3.8447387692307693,3.8684234615384616,3.892108153846154,3.9157928461538463,3.9394775384615386,3.963162230769231,3.9868469230769232,4.0105316153846156,4.034216307692308,{"y":4.057901,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.76,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.731,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.329,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.833,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.414,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.01,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.465,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.81,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.208,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.82,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.58,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.75,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€5.98Average Price Target€4.97Lowest Price Target€4.06
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on DE:1FW2
Unknown Analyst
CICC
Not Ranked
CICC
€5.26
Buy
36.74%
Upside
Reiterated
06/01/26
CICC Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Morgan Stanley Analyst forecast on DE:1FW2
Laurence Tam
Morgan Stanley
Morgan Stanley
€5.48
Buy
42.43%
Upside
Reiterated
06/01/26
Analysts Are Bullish on Top Healthcare Stocks: Autolus Therapeutics (AUTL), Wuxi Biologics (Cayman) (WXIBF)
UBS Analyst forecast on DE:1FW2
Unknown Analyst
UBS
Not Ranked
UBS
€5.41
Buy
40.44%
Upside
Reiterated
05/26/26
UBS Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Citi Analyst forecast on DE:1FW2
Unknown Analyst
Citi
Not Ranked
Citi
€4.61
Buy
19.64%
Upside
Reiterated
04/13/26
Citi Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Zhongtai Securities Analyst forecast on DE:1FW2
Unknown Analyst
Zhongtai Securities
Not Ranked
Zhongtai Securities
€5.49→€5.52
Buy
43.29%
Upside
Reiterated
04/09/26
Zhongtai Securities Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Guotai Haitong Analyst forecast on DE:1FW2
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
€5.98
Buy
55.22%
Upside
Reiterated
04/06/26
Guotai Haitong Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Bank of China Analyst forecast on DE:1FW2
Unknown Analyst
Bank of China
Not Ranked
Bank of China
€4.06
Buy
5.40%
Upside
Reiterated
03/26/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Bank of China
CLSA Analyst forecast on DE:1FW2
Unknown Analyst
CLSA
Not Ranked
CLSA
€5.19
Buy
34.74%
Upside
Reiterated
03/26/26
CLSA Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Daiwa Analyst forecast on DE:1FW2
Unknown Analyst
Daiwa
Not Ranked
Daiwa
€4.61
Buy
19.64%
Upside
Reiterated
03/26/26
Daiwa Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
UOB Kay Hian Analyst forecast on DE:1FW2
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
€4.94
Buy
28.19%
Upside
Reiterated
03/26/26
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from UOB Kay Hian
CMB International Securities Analyst forecast on DE:1FW2
Jill Wu
CMB International Securities
CMB International Securities
€4.28
Buy
11.10%
Upside
Reiterated
03/26/26
WuXi Biologics: Robust Backlog, High-Margin Growth Drivers, and Capacity Expansion Underpin Buy Rating
Bank of America Securities Analyst forecast on DE:1FW2
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
€4.33
Hold
12.52%
Upside
Reiterated
03/25/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Hold from Bank of America Securities
China Renaissance Analyst forecast on DE:1FW2
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
€5.95
Buy
54.48%
Upside
Reiterated
02/10/26
China Renaissance Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Nomura Analyst forecast on DE:1FW2
Jialin Zhang
Nomura
Nomura
€4.1
Buy
6.43%
Upside
Reiterated
11/28/25
Goldman Sachs Analyst forecast on DE:1FW2
Ziyi Chen
Goldman Sachs
Goldman Sachs
€3.21→€3.67
Hold
-4.57%
Downside
Reiterated
10/17/25
Goldman Sachs Keeps Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CICC Analyst forecast on DE:1FW2
Unknown Analyst
CICC
Not Ranked
CICC
€5.26
Buy
36.74%
Upside
Reiterated
06/01/26
CICC Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Morgan Stanley Analyst forecast on DE:1FW2
Laurence Tam
Morgan Stanley
Morgan Stanley
€5.48
Buy
42.43%
Upside
Reiterated
06/01/26
Analysts Are Bullish on Top Healthcare Stocks: Autolus Therapeutics (AUTL), Wuxi Biologics (Cayman) (WXIBF)
UBS Analyst forecast on DE:1FW2
Unknown Analyst
UBS
Not Ranked
UBS
€5.41
Buy
40.44%
Upside
Reiterated
05/26/26
UBS Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Citi Analyst forecast on DE:1FW2
Unknown Analyst
Citi
Not Ranked
Citi
€4.61
Buy
19.64%
Upside
Reiterated
04/13/26
Citi Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Zhongtai Securities Analyst forecast on DE:1FW2
Unknown Analyst
Zhongtai Securities
Not Ranked
Zhongtai Securities
€5.49→€5.52
Buy
43.29%
Upside
Reiterated
04/09/26
Zhongtai Securities Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Guotai Haitong Analyst forecast on DE:1FW2
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
€5.98
Buy
55.22%
Upside
Reiterated
04/06/26
Guotai Haitong Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Bank of China Analyst forecast on DE:1FW2
Unknown Analyst
Bank of China
Not Ranked
Bank of China
€4.06
Buy
5.40%
Upside
Reiterated
03/26/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Bank of China
CLSA Analyst forecast on DE:1FW2
Unknown Analyst
CLSA
Not Ranked
CLSA
€5.19
Buy
34.74%
Upside
Reiterated
03/26/26
CLSA Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Daiwa Analyst forecast on DE:1FW2
Unknown Analyst
Daiwa
Not Ranked
Daiwa
€4.61
Buy
19.64%
Upside
Reiterated
03/26/26
Daiwa Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
UOB Kay Hian Analyst forecast on DE:1FW2
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
€4.94
Buy
28.19%
Upside
Reiterated
03/26/26
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from UOB Kay Hian
CMB International Securities Analyst forecast on DE:1FW2
Jill Wu
CMB International Securities
CMB International Securities
€4.28
Buy
11.10%
Upside
Reiterated
03/26/26
WuXi Biologics: Robust Backlog, High-Margin Growth Drivers, and Capacity Expansion Underpin Buy Rating
Bank of America Securities Analyst forecast on DE:1FW2
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
€4.33
Hold
12.52%
Upside
Reiterated
03/25/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Hold from Bank of America Securities
China Renaissance Analyst forecast on DE:1FW2
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
€5.95
Buy
54.48%
Upside
Reiterated
02/10/26
China Renaissance Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Nomura Analyst forecast on DE:1FW2
Jialin Zhang
Nomura
Nomura
€4.1
Buy
6.43%
Upside
Reiterated
11/28/25
Goldman Sachs Analyst forecast on DE:1FW2
Ziyi Chen
Goldman Sachs
Goldman Sachs
€3.21→€3.67
Hold
-4.57%
Downside
Reiterated
10/17/25
Goldman Sachs Keeps Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Wuxi Biologics (Cayman)

3 Months
Jialin ZhangNomura
Success Rate
6/8 ratings generated profit
75%
Average Return
+16.49%
Copying Jialin Zhang's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +16.49% per trade.
1 Year
Yang HuangJ.P. Morgan
Success Rate
4/4 ratings generated profit
100%
Average Return
+46.20%
Copying Yang Huang's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +46.20% per trade.
2 Years
Michael Luo CFACLSA
Success Rate
7/7 ratings generated profit
100%
Average Return
+64.70%
Copying Michael Luo CFA's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +64.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1FW2 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
1
4
4
Buy
3
10
12
10
5
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
11
14
15
9
In the current month, 1FW2 has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1FW2 average Analyst price target in the past 3 months is 4.97.
Each month's total comprises the sum of three months' worth of ratings.

1FW2 Financial Forecast

1FW2 Earnings Forecast

Next quarter’s earnings estimate for 1FW2 is €0.07 with a range of €0.07 to €0.07. The previous quarter’s EPS was €0.07. 1FW2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 1FW2 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1FW2 is €0.07 with a range of €0.07 to €0.07. The previous quarter’s EPS was €0.07. 1FW2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 1FW2 has Performed in-line its overall industry.

1FW2 Sales Forecast

Next quarter’s sales forecast for 1FW2 is €1.42B with a range of €1.42B to €1.42B. The previous quarter’s sales results were €1.42B. 1FW2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 1FW2 has Performed in-line its overall industry.
Next quarter’s sales forecast for 1FW2 is €1.42B with a range of €1.42B to €1.42B. The previous quarter’s sales results were €1.42B. 1FW2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 1FW2 has Performed in-line its overall industry.

1FW2 Stock Forecast FAQ

What is DE:1FW2’s average 12-month price target, according to analysts?
Based on analyst ratings, Wuxi Biologics (Cayman) Inc.’s 12-month average price target is 4.97.
    What is DE:1FW2’s upside potential, based on the analysts’ average price target?
    Wuxi Biologics (Cayman) Inc. has 29.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Wuxi Biologics (Cayman) Inc. a Buy, Sell or Hold?
          Wuxi Biologics (Cayman) Inc. has a consensus rating of Strong Buy, which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Wuxi Biologics (Cayman) Inc.’s share price target?
            The average share price target for Wuxi Biologics (Cayman) Inc. is 4.97. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €5.98 ,and the lowest forecast is €4.06. The average share price target represents 29.11% Increase from the current price of €3.85.
              What do analysts say about Wuxi Biologics (Cayman) Inc.?
              Wuxi Biologics (Cayman) Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Wuxi Biologics (Cayman) Inc.?
                To buy shares of DE:1FW2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.